Abstract
Individuals who are obese are at a greater risk of developing gastric cancer. They are however also hyperleptinaemic. Chronic leptin treatment has been shown to upregulate numerous cancer-causing genes in the stomach of male Sprague-Dawley rats. It is however unclear if leptin enhances the effect of gastric carcinogens in vivo. This study was therefore done to investigate the effect of leptin on gastric carcinogenesis in rats treated with N-methyl-N’-nitro-N-nitrosoguanidine (MNNG). Twenty-four, 6-week old male Sprague-Dawley rats were divided equally into three groups: G1 served as age-matched controls; G2 was treated with MNNG in drinking water ad libitum (200 mg L−1); G3 was given leptin and MNNG. Rats were euthanized after 40 weeks of treatment and their stomachs were removed for histopathology, microarray, and RT-qPCR analysis. Fisher’s exact test and one-way ANOVA were used to analyse the data. Fifty percent of the MNNG-treated rats developed gastric hyperplasia (p < 0.05), but there was no significant change in any carcinogenic genes. Concurrent MNNG and leptin treatment however induced hyperplasia, dysplasia, hypertrophy, and adenocarcinoma in 75% (6/8) of the rats; with upregulation of microRNAs, olfactory receptors, Hey2 (transcription factor), Tmed2 (vesicular trafficking), and Lcn11 (cell proliferation) genes. It appears that leptin enhances MNNG- induced tumour growth in stomachs of Sprague-Dawley rats and its role in gastric cancer requires further scrutiny.
Similar content being viewed by others
References
Park HK, Ahima RS (2014) Leptin signaling. F1000Prime Rep 4(6):73
Trayhurn P, Bing C (2006) Appetite and energy balance signals from adipocytes. Philos Trans R Soc B 361(1471):1237–1249
Harris R (2014) Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta 1842(3):414–423
Park HK, Ahima RS (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64(1):24–34
Wauman J, Zabeau L, Tavernier J (2017) The leptin receptor complex: heavier than expected? Front Endocrinol 8:30
Ibrahim HS, Omar E, Froemming GRA, Singh HJ (2013) Leptin increases blood pressure and markers of endothelial activation during pregnancy in rats. Biomed Res Int 2013:1–6
Ibrahim HS, Froemming GRA, Omar E, Singh HJ (2014) ACE2 activation by xanthenone prevents leptin-induced increases in blood pressure and proteinuria during pregnancy in Sprague-Dawley rats. Reprod Toxicol 49:155–161
Haron MN, D’Souza UJA, Jaafar H, Zakaria R, Singh HJ (2010) Exogenous leptin administration decreases sperm count and increases the fraction of abnormal sperm in adult rats. Fertil Steril 93:322–324
Abbasihormozi S, Shahverdi A, Kouhkan A, Cheraghi J, Akhlaghi AA, Kheimeh A (2013) Relationship of leptin administration with production of reactive oxygen species, sperm DNA fragmentation, sperm parameters and hormone profile in the adult rat. Arch Gynecol Obstet 287(6):1241–1249
Almabhouh FA, Osman K, Siti Fatimah I, Sergey G, Gnanou J, Singh HJ (2015) Effects of leptin on sperm count and morphology in Sprague-Dawley rats and their reversibility following a 6-week recovery period. Andrologia 47(7):751–758
Almabhouh F, Singh HJ (2017) Leptin adversely affects the transition of histone-to-protamine during spermatogenesis in Sprague-Dawley rats. Andrologia 25(3):13–20
Tilg H, Moschen AR (2014) Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol 28(4):599–610
Park J, Morley TS, Kim M, Clegg DJ, Scherer PE (2014) Obesity and cancer—mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10(8):455–465
Global Burden of Disease Cancer Collaboration (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015. JAMA Oncol 3(4):524
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295
Lee KN, Choi HS, Yang SY, Park HK, Lee YY, Lee OY et al (2014) The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms. Biochem Biophys Res Commun 446(4):822–829
Isyraqiah F, Kutty MK, Durairajanayagam D, Salim N, Singh H (2018) Leptin induces the expression of tumorigenic genes in the gastric mucosa of male Sprague-Dawley rats. Exp Biol Med 243(14):1118–1124
Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD et al (2004) Chemoprevention of gastric cancer by celecoxib in rats. Gut 53(2):195–200
Tsukamoto H, Mizoshita T, Katano T, Hayashi N, Ozeki K, Ebi M et al (2015) Preventive effect of rebamipide on N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Exp Toxicol Pathol 67(3):271–277
Takahashi M, Kokubo T, Furukawa F, Yuji K (1983) Effect of high salt diet on rat gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitorsoguanidine. GANN Jpn J Cancer Res 74:28–34
Wakui S, Motohashi M, Muto T, Takahashi H, Hano H, Jutabha P et al (2011) Sex-associated difference in estrogen receptor β expression in N-methyl-N′-nitro-N- nitrosoguanidine-induced gastric cancers in rats. Comp Med 61(5):412–418
Alizadeh A, Afrouzan H, Dinparast-Djadid N, Sawaya A, Azizian S, Hemmati H et al (2015) Chemoprotection of MNNG-initiated gastric cancer in rats using Iranian propolis. Arch Iran Med 18(1):18–23
Badr El-Din NK, Abdel Fattah SM, Pan D, Tolentino L, Ghoneum M (2016) Chemopreventive activity of MGN-3/Biobran against chemical induction of glandular stomach carcinogenesis in rats and its apoptotic effect in gastric cancer cells. Integr Cancer Ther 15(4):NP26–NP34
Weisburger JH, Conrad Jones R, Barnes WS, Pegg AE (1988) Mechanisms of differential strain sensitivity in gastric carcinogenesis. Jpn J Cancer Res 79:1304–1310
Velmurugan B, Bhuvaneswari V, Nagini S (2003) Effect of S-allylcysteine on oxidant-antioxidant status during N-methyl-N’-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats. Asia Pac J Clin Nutr 12(4):488–494
Nishikawa A, Tanakamaru ZY, Furukawa F, Lee IS, Kasahara KI, Ikezaki S et al (1998) Chemopreventive activity of oltipraz against induction of glandular stomach carcinogenesis in rats by N-methyl-N’-nitro-N-nitrosoguanidine. Carcinogenesis 19(2):365–368
Acknowledgements
The authors wish to acknowledge the staff of Laboratory Animal Care Unit (LACU) and Institute of Medical Molecular Biotechnology (IMMB) for their technical help and support.
Funding
This study was supported by 600-IRMI/MyRA 5/3/GIP (019/2017) Research Grant.
Author information
Authors and Affiliations
Contributions
FI conducted the experiments, analysed the data, interpreted the results, and wrote the manuscript; MKK participated in the study design, analysed histology slides and microarray data, helped in the preparation of the manuscript and reviewed the manuscript; DD interpreted the results and reviewed the manuscript; HJS participated in the study design, provided the overall supervision, interpreted the results, helped in the preparation of the manuscript and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Isyraqiah, F., Kutty, M.K., Durairajanayagam, D. et al. Leptin enhances N-methyl-N’-nitro-N-nitrosoguanidine (MNNG)-induced tumour growth in gastric mucosa of male Sprague-Dawley rats. Mol Biol Rep 46, 5967–5975 (2019). https://doi.org/10.1007/s11033-019-05030-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-019-05030-z